Weusten, Bas L. A. M;
Bisschops, Raf;
Dinis-Ribeiro, Mario;
di Pietro, Massimiliano;
Pech, Oliver;
Spaander, Manon C. W;
Baldaque-Silva, Francisco;
Barret, Maximilien;
Coron, Emmanuel;
Fernández-Esparrach, Glòria;
Fitzgerald, Rebecca C;
Jansen, Marnix;
Jovani, Manol;
Marques-de-Sa, Ines;
Rattan, Arti;
Tan, W. Keith;
Verheij, Eva P. D;
Zellenrath, Pauline A;
Triantafyllou, Konstantinos;
Pouw, Roos E.
This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). It is an update of the previous (2017) Position Statement on the endoscopic management of Barrett esophagus....
Black, Christopher;
Paine, Peter;
Agrawal, Anurag;
Aziz, Imran;
Eugenicos, Maria;
Houghton, Lesley;
Hungin, Pali;
Overshott, Ross;
Rudd, Sheryl;
Corsetti, Maura;
Ford, Alexander.
Functional dyspepsia (FD) is a common disorder of gut–brain interaction, affecting approximately 7% of individuals in the community, with most patients managed in primary care. The last British Society of Gastroenterology (BSG) guideline for the management of dyspepsia was published in 1996. In the int...
This guideline covers diagnosing and managing gastro-oesophageal reflux disease in children and young people (under 18s). It aims to raise awareness of symptoms that need investigating and treating, and to reassure parents and carers that regurgitation is common in infants under 1 year....
La hemorragia digestiva alta (HDA) es una emergencia médica relativamente frecuente,
habiéndose estimado una incidencia anual de 40 a 150 casos por 100 000 personas (1, 2). La
HDA se suele dividir en dos tipos: variceal y no variceal. La mayoría de casos de HDA son de tipo
no variceal, y se incluye la...
Jones, N. L;
Koletzko, S;
Goodman, K;
Bontems, P;
Cadranel, S;
Casswall, T;
Czinn, S;
Gold, B. D;
Guarner, J;
Elitsur, Y;
Homan, M;
Kalach, N;
Kori, M;
Madrazo, A;
Megraud, F;
Papadopoulou, A;
Rowland, M.
BACKGROUND: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition...
Farrell, B;
Pottie, K;
Thompson, W;
Boghossian, T;
Pizzola, L;
Rashid, F. J;
Rojas-Fernandez, C;
Walsh, K;
Welch, V;
Moayyedi, P.
OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper or stop proton pump inhibitors (PPIs); to focus on the highest level of evidence available and seek input from primary care professionals in the guideline development, review, and endors...
Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Antibacterianos/uso terapéutico,
Inhibidores de la Bomba de Protones/uso terapéutico,
Bismuto/uso terapéutico,
Algoritmos,
Técnica Delphi,
Quimioterapia Combinada,
Gastritis/complicaciones,
Infecciones por Helicobacter,
Helicobacter pylori,
Probióticos,
Inhibidores de la Bomba de Protones,
Recurrencia,
Terapia Recuperativa,
Neoplasias Gástricas,
Úlcera Gástrica,
Insuficiencia del Tratamiento,
Gastritis/tratamiento farmacológico,
Infecciones por Helicobacter/tratamiento farmacológico,
Helicobacter pylori/efectos de los fármacos
Fock, KM;
Talley, N;
Goh, KL;
Sugano, K;
Katelaris, P;
Holtmann, G;
Pandolfino, JE;
Sharma, P;
Ang, TL;
Hongo, M;
Wu, J;
Chen, M;
Choi, MG;
Law, NM;
Sheu, BS;
Zhang, J;
Ho, KY;
Sollano, J;
Rani, AA;
Kositchaiwat, C;
Bhatia, S.
"OBJECTIVE:
Since the publication of the Asia-Pacific consensus on gastro-oesophageal reflux disease in 2008, there has been further scientific advancement in this field. This updated consensus focuses on proton pump inhibitor-refractory reflux disease and Barrett's oesophagus.
METHODS:
A steering commi...
La finalidad de esta guía es proporcionar unas recomendaciones para el uso de Inhibidores de la Bomba de Protones (IBP), tanto en el ámbito de la atención primaria como en el de atención especializada. Su objetivo principal es dar a conocer las indicaciones de los IBP en prevención primaria de event...
